Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950135-96-000721
Filing Date
1996-02-06
Accepted
1996-02-06 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 LA JOLLA PHARMACEUTICALS AMENDMENT NO. 1 SC 13G/A 6817
  Complete submission text file 0000950135-96-000721.txt   8830
Mailing Address P.O. BOX 7842 121 EAST WILSON STREET MADISON WI 53702
Business Address 121 EAST WILSON STREET MADISON WI 53707 6082668824
STATE OF WISCONSIN INVESTMENT BOARD (Filed by) CIK: 0000854157 (see all company filings)

EIN.: 396006423 | State of Incorp.: WI | Fiscal Year End: 0630
SIC: 0000

Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 6194526600
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

EIN.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44849 | Film No.: 96511447
SIC: 2834 Pharmaceutical Preparations